In a nutshell This article investigated the safety and effectiveness of atezolizumab (Tecentriq) plus chemotherapy for the treatment of extensive-stage small-cell lung cancer (SCLC). The authors concluded that this treatment is safe and can improve survival of these patients. Some background Patients with extensive-stage SCLC...
Read More
In a nutshell This study wanted to find out how well a treatment for lung cancer called stereotactic body radiation therapy works in patients with lung cancer that cannot be surgically removed. The study found that this treatment is effective in patients with lung cancer, and a higher dose of radiation is not any better than a lower dose. Some...
Read More
In a nutshell This study wanted to find out how effective it is to perform radiation therapy on the brain to prevent lung cancer spreading to the brain. The study found that by performing radiation therapy on the brain, there was a lower chance of the cancer spreading to the brain, but it was not clear if it improved overall survival. Some background...
Read MoreIn a nutshell This trial aims to test the effectiveness of a new drug called RRx-001 in patients with small cell carcinoma. The main outcome measured will be how long the patients go without cancer growing or spreading (progression-free survival). The study is being conducted in the United States, Orange City, Florida. The details...
Read More
During July and early August of 2018, the Harris Poll in association with the American Society of Clinical Oncologists (ASCO’s) conducted a poll of 4,887 U.S. adults, 1001 of these have or had cancer. This second annual National Cancer Opinion Survey explored a wide range of topics. The findings clearly describe disparities in the care patients with...
Read More
In a nutshell This article investigated the safety and effectiveness of thermal ablation (TA) compared to stereotactic radiation therapy (SRT) for the treatment of non-small-cell lung cancer (NSCLC). The authors concluded that both thermal ablation and stereotactic radiation are safe and can improve survival of these patients. Some...
Read MoreIn a nutshell This trial aims to evaluate the safety and effectiveness of the combination of nivolumab (Opdivo), ipilimumab (Yervoy), and paclitaxel (Taxol) for treating lung cancer. The main outcome that will be measured is survival without the tumor growing or spreading. The study is taking place in Durham, North Carolina, the United States. The...
Read More
In a nutshell This study wanted to find out if treating lung cancer with nivolumab (Opdivo) is better than treating it with docetaxel (Taxotere), specifically for lung cancer than has already been treated before. The study found that nivolumab worked better and was safer than docetaxel in treating lung cancer. Some background Nivolumab and docetaxel...
Read More
In a nutshell This study examined how safe and effective is biosimilar ABP 215 in non-small cell lung cancer (NSCLC), compared to bevacizumab (Avastin). This study concluded that this drug is as safe and effective as bevacizumab in these patients. Some background Non-small cell lung cancer (NSCLC) is the most common type of lung...
Read More
In a nutshell This study wanted to find out if the medication brigatinib (Alunbrig) is better than crizotinib (Xalkori) in treating patients with lung cancer. The study found that survival was significantly longer in patients who were treated with brigatinib compared to those treated with crizotinib. Some background Brigatinib and crizotinib are a...
Read More
In a nutshell This study wanted to find out which medication is better for treating lung cancer that has spread to the brain or spinal cord, crizotinib (Xalkori) or alectinib (Alecensa). The study found that alectinib worked better than crizotinib for treatment of tumors of the brain and spinal cord. Some background Alectinib and crizotinib are two...
Read More
In a nutshell This study wanted to find out how well radiotherapy treatment works for people with stage 4 non-small cell lung cancer. The study found that overall survival was improved in patients who had radiotherapy treatment compared to those who did not. Some background There are a number of options for treatment of non-small cell lung...
Read More
